Buspirone hydrochloride
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Buspirone hydrochloride
- Generic name
- BUSPIRONE HYDROCHLORIDE
- Manufacturer
- A-S Medication Solutions
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- fdacb3d3-f574-431a-8324-2278edc16bce
- SPL ID
- 4e0c6d17-93b2-4388-9f5f-9365be5dcde4
- Version
- 3
- Effective date
- 2026-10-15
- Source export date
- 2026-11-13
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-13/a79c47b73cf1c0b9829667844daa083c5114cf268a1839f963bc5617e9060c4f/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- 8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
- Import run
- 20261116T150851Z
- Imported at
- 2026-11-16 16:20:34
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 202087 | derived:openfda.application_number |
| application number | ANDA202087 | openfda.application_number | |
| brand name | Buspirone hydrochloride | openfda.brand_name | |
| generic name | BUSPIRONE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | A-S Medication Solutions | openfda.manufacturer_name | |
| ndc | package | 50090-8118-0 | openfda.package_ndc |
| ndc | package | 50090-8118-1 | openfda.package_ndc |
| ndc | product | 50090-8118 | openfda.product_ndc |
| ndc11 | package | 50090811801 | derived:openfda.package_ndc |
| ndc11 | package | 50090811800 | derived:openfda.package_ndc |
| rxcui | 866111 | openfda.rxcui | |
| spl id | 4e0c6d17-93b2-4388-9f5f-9365be5dcde4 | id | |
| spl set id | fdacb3d3-f574-431a-8324-2278edc16bce | set_id | |
| unii | 207LT9J9OC | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS The administration of buspirone hydrochloride tablets to a patient taking a monoamine oxidase inhibitor (MAOI) may pose a hazard. There have been reports of the occurrence of elevated blood pressure when buspirone hydrochloride has been added to a regimen including an MAOI. Therefore, it is recommended that buspirone hydrochloride tablets not be used concomitantly with an MAOI.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS (See also PRECAUTIONS ) Commonly Observed The more commonly observed untoward events associated with the use of buspirone hydrochloride tablets not seen at an equivalent incidence among placebo-treated patients include dizziness, nausea, headache, nervousness, lightheadedness, and excitement.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.